92. [IF=5.7] Lili Yang et al."Herbal HuoXueTongFu Formula with anti-inflammatory and fibrinolytic activity regulation for the prevention of postoperative peritoneal adhesions."Frontiers in Immunology.2025 Jan;15: 91. [IF=4.7] Zhiguang Huang et al."Jiawei Erzhiwan Ameliorates Androgenetic Alopecia by Regulating the SIRT1/JNK/p38 MAPK Pathway."Drug Design Development and Therapy. 90. [IF=4.8] Yan Li et al."HSYA ameliorates venous thromboembolism by depleting the formation of TLR4/NF-κB pathway-dependent neutrophil extracellular traps."INTERNATIONAL IMMUNOPHARMACOLOGY.2024 Dec;143:113534 89. [IF=4.8] Chun-Ying Wu et al."Extraction of hydroxy safflower yellow A and anhydroxysafflor yellow B from safflower florets using natural deep eutectic solvents: Optimization, biological activity and molecular docking."Food Bioscience.2025 Jun;68:106418 88. [IF=5.3] Li Teng et al."Metabolomics integrated with network pharmacology of blood-entry constituents reveals the bioactive component of Xuefu Zhuyu decoction and its angiogenic effects in treating traumatic brain injury."Chinese Medicine.2024 Dec;19(1):1-16 87. [IF=6] Yi-Fang Gao et al."The profile of plant bioactive compounds in Xinjiang, China unifloral safflower honey and their inhibitory on ACE, and determination of the mechanism of inhibition."LWT-FOOD SCIENCE AND TECHNOLOGY.2024 Oct;210:116806 86. [IF=1.9] Shibiao Ding et al."Safflower Alleviates Pulmonary Arterial Hypertension by Inactivating NLRP3: A Combined Approach of Network Pharmacology and Experimental Verification."Clinical Respiratory Journal.2024 Aug;18(8):e13826 85. [IF=7.1] Li Ning et al."Transplantation of human endometrial perivascular stem cells with hydroxy saffron yellow A promotes uterine repair in rats."Stem Cell Research & Therapy.2024 Dec;15(1):1-15 84. [IF=6.7] Wenxuan Wang et al."Hydroxysafflor yellow A ameliorates alcohol-induced liver injury through PI3K/Akt and STAT3/NF-κB signaling pathways."PHYTOMEDICINE.2024 Jun;:155814 83. [IF=8.6] Kai-Yu Ruan et al."Bio-derived solvent based salt-responsive system for simultaneous extraction and in-situ enrichment of polysaccharides and phenolics from Carthamus tinctorius L. flower."SEPARATION AND PURIFICATION TECHNOLOGY".2024 Dec;349:127795 82. [IF=5.4] Yang Wang et al."Buyang huanwu decoction promotes remyelination via miR-760-3p/GPR17 axis after intracerebral hemorrhage."JOURNAL OF ETHNOPHARMACOLOGY".2024 Jun;328:118126 81. [IF=5.4] Yanqiu Sun et al."Network pharmacology integrated with experimental validation revealed the mechanism of Fengshi Gutong Capsule in the treatment of osteoarthritis."JOURNAL OF ETHNOPHARMACOLOGY.2023 Oct;:117261 80. [IF=5.4] Menghan Cheng et al."A novel strategy of integrating network pharmacology and transcriptome reveals antiapoptotic mechanisms of Buyang Huanwu Decoction in treating intracerebral hemorrhage."JOURNAL OF ETHNOPHARMACOLOGY.10.1016/j.jep.2023.117123 79. [IF=3.8] En Hu et al."Metabolomics reveals the effects of hydroxysafflor yellow A on neurogenesis and axon regeneration after experimental traumatic brain injury."PHARMACEUTICAL BIOLOGY.2023;61(1):1054-1064 78. [IF=5.4] Dandan Feng et al."N6-methyladenosine profiling reveals that Xuefu Zhuyu decoction upregulates METTL14 and BDNF in a rat model of traumatic brain injury."JOURNAL OF ETHNOPHARMACOLOGY.2023 Dec;317:116823 77. [IF=6] Rong-Shuai Hu et al."Comparative study on optimization of NADES extraction process by dual models and antioxidant activity of optimum extraction from Chuanxiong-Honghua."LWT-FOOD SCIENCE AND TECHNOLOGY.2023 Jul;184:114991 76. [IF=4.46] Jiaxi Chen et al."Hydroxysafflor yellow A protects against colitis in mice by suppressing pyroptosis via inhibiting HK1/NLRP3/GSDMD and modulating gut microbiota."TOXICOLOGY AND APPLIED PHARMACOLOGY.2023 May;467:116494 75. [IF=5.195] Zelin Lai et al."Hydroxysafflor yellow a confers neuroprotection against acute traumatic brain injury by modulating neuronal autophagy to inhibit NLRP3 inflammasomes."JOURNAL OF ETHNOPHARMACOLOGY.2023 May;308:116268 74. [IF=0] Xiaoqing Song et al."Protective effect of hydroxysafflor yellow A on MSCs against senescence induced by D-galactose."Chinese Herbal Medicines.2022 Dec;: 73. [IF=1.698] Mengjie Xue et al."Illumination on Chemical Compounds from Qufeng Zhitong Capsule and Its Potential Pharmacological Mechanism against Rheumatoid Arthritis Based on UHPLC/Q-Orbitrap-MS Combined with Network Pharmacology Analysis."International Journal of A 72. [IF=6.656] Jiling Feng et al."Luhong Formula and Hydroxysafflor yellow A protect cardiomyocytes by inhibiting autophagy."PHYTOMEDICINE.2023 Feb;110:154636 71. [IF=7.425] Zhen Yan et al."Composition of major quinochalcone hydroxysafflor yellow A and anhydrosafflor yellow B is associated with colour of safflower (Carthamus tinctorius) during colour-transition but not with overall antioxidant capacity: a study on 144 cultiva 70. [IF=2.65] Jing Zhou et al."Buyang Huanwu Decoction: A Traditional Chinese Medicine, Promotes Lactate-Induced Angiogenesis in Experimental Intracerebral Hemorrhage."Evidence-based Complementary and Alternative Medicine.2022 Oct 30;2022:4063315 69. [IF=7.419] Yule Wang et al."Discovery of anti-stroke active substances in Guhong injection based on multi-phenotypic screening of zebrafish."BIOMEDICINE & PHARMACOTHERAPY.2022 Nov;155:113744 68. [IF=2.464] Zhou Huifen et al."Pharmacokinetic-Pharmacodynamic Modeling of Active Components from Salvia miltiorrhiza (Danshen) and Carthamus tinctorius (Honghua) in Focal Cerebral Ischemia Rats."Revista Brasileira de Farmacognosia-Brazilian Journal of Pharmacognosy. 67. [IF=6.53] Qianqian Chen et al."Pharmacokinetic-pharmacodynamic modeling analysis for hydroxysafflor yellow A-calycosin in compatibility in normal and cerebral ischemic rats: A comparative study."Biomed Pharmacother. 2022 Jun;150:112950 66. [IF=3.269] Dan Su et al."Hydroxysafflor yellow A inhibits the proliferation, migration, and invasion of colorectal cancer cells through the PPARγ/PTEN/Akt signaling pathway."Bioengineered. 2021;12(2):11533-11543 65. [IF=6.529] Ting Shang et al."The combination of four main components in Xuebijing injection improved the preventive effects of Cyclosporin A in acute graft-versus-host disease mice by protecting intestinal microenvironment."Biomed Pharmacother. 2022 Apr;148:112675 64. [IF=5.34] Yule Wang et al."Guhong injection promotes post-stroke functional recovery via attenuating cortical inflammation and apoptosis in subacute stage of ischemic stroke."Phytomedicine. 2022 May;99:154034 63. [IF=0.533] Jinyan Jiang et al."Comparative studies of the anti-thrombotic effects of saffron and HongHua based on network pharmacology."Trop J Pharm Res. 2020 Nov;19(7):1441-1448 62. [IF=1.902] Rui Yao et al."Pharmacokinetic characteristics of hydroxysafflor yellow A in normal and diabetic cardiomyopathy mice."Biomed Chromatogr. 2021 Oct;35(10):e5173 61. [IF=1.902] Ting Zhang et al."The influence of essential oils from ZhaLi NuSi Prescription on the pharmacokinetics of its non-volatile components in normal rats."Biomedical Chromatography. 2021 Oct 21 60. [IF=3] Qu Lala et al."Phenotypic assessment and ligand screening of ETA/ETB receptors with label-free dynamic mass redistribution assay."N-S Arch Pharmacol. 2020 Jun;393(6):937-950 59. [IF=3.098] Donglai Zhou et al."Hydroxysafflor Yellow A mitigated myocardial ischemia/reperfusion injury by inhibiting the?activation of the JAK2/STAT1 pathway."Int J Mol Med. 2019 Aug;44(2):405-416 58. [IF=4.225] Shang Ting et al."Xuebijing Injection Maintains GRP78 Expression to Prevent Candida albicans–Induced Epithelial Death in the Kidney."Front Pharmacol. 2020 Jan;0:1416 57. [IF=4.36] Li Lin et al."Study on the alleviation of Fengshi Gutong capsule on rheumatoid arthritis through integrating network pharmacology and experimental exploration."J Ethnopharmacol. 2021 Nov;280:114471 56. [IF=4.545] Na Wu et al."Hydroxysafflor yellow A promotes apoptosis via blocking autophagic flux in liver cancer."Biomed Pharmacother. 2021 Apr;136:111227 55. [IF=5.34] Jing Zhang et al."Application of “spider-web” mode in discovery and identification of Q-markers from Xuefu Zhuyu capsule."Phytomedicine. 2020 Oct;77:153273 54. [IF=5.81] Fangma Yijia et al."Hydroxysafflor Yellow A and Anhydrosafflor Yellow B Protect Against Cerebral Ischemia/Reperfusion Injury by Attenuating Oxidative Stress and Apoptosis via the Silent Information Regulator 1 Signaling Pathway."Front Pharmacol. 2021 Sep 53. [IF=7.271] Teng Li et al."Integrated metabolomics and network pharmacology to reveal the mechanisms of hydroxysafflor yellow A against acute traumatic brain injury."Comput Struct Biotec. 2021 Jan;19:1002 52. [IF=7.514] Xin Tong et al."Greener extraction process and enhanced in vivo bioavailability of bioactive components from Carthamus tinctorius L. by natural deep eutectic solvents."Food Chem. 2021 Jun;348:129090 51. [IF=7.514] Liuwei Zhao et al."Safflomin A: A novel chemical marker for Carthamus tinctorius L. (Safflower) monofloral honey."Food Chem. 2022 Jan;366:130584 50. [IF=2.1] Bin Ni et al."Hydroxysafflor yellow A protects against angiotensin II?induced hypertrophy."Mol Med Rep. 2018 Oct;18(4):3649-3656 49. [IF=2.173] Wenlu Li et al."Hydroxysafflor yellow A protects methylglyoxal-induced injury in the cultured human brain microvascular endothelial cells."Neurosci Lett. 2013 Aug;549:146 48. [IF=2.233] Zhenzhen Ni et al."Inhibitory effects of hydroxysafflor yellow A on the formation of advanced glycation endproducts in vitro."Biological & Pharmaceutical Bulletin. 2012 Aug 31 47. [IF=2.547] Jing Zhou et al."Pharmacokinetic Study on Protocatechuic Aldehyde and Hydroxysafflor Yellow A of Danhong Injection in Rats with Hyperlipidemia."Pharmacology. 2018;102(3-4):154-160 46. [IF=2.896] Lu Wang et al."Rapid assay for testing superoxide anion radical scavenging activities to natural pigments by ultra-high performance liquid chromatography-diode-array detection method."Anal Methods-Uk. 2015 Feb;7(4):1535-1542 45. [IF=3.046] Liwei Dong et al."Echinacoside induces apoptotic cancer cell death by inhibiting the nucleotide pool sanitizing enzyme MTH1."Oncotargets Ther. 2015; 8: 3649–3664 44. [IF=3.845] Zhang Xianhua et al."Danshen-Chuanxiong-Honghua Ameliorates Cerebral Impairment and Improves Spatial Cognitive Deficits after Transient Focal Ischemia and Identification of Active Compounds."Front Pharmacol. 2017 Jul;0:452 43. [IF=5.81] Yu Li et al."Pharmacokinetics of Active Components From Guhong Injection in Normal and Pathological Rat Models of Cerebral Ischemia: A Comparative Study."Front Pharmacol. 2018 May;0:493 42. [IF=10.618] Yao-Xiong Huang et al."Versatile on-stage microfluidic system for long term cell culture, micromanipulation and time lapse assays."Biosens Bioelectron. 2018 Mar;101:66 41. Zhang, Jing, et al. "Application of “spider-web” mode in discovery and identification of Q-markers from Xuefu Zhuyu capsule." Phytomedicine 77 (2020): 153273.https://doi.org/10.1016/j.phymed.2020.153273 40. Jiang, Jinyan, et al. "Comparative studies of the anti-thrombotic effects of saffron and HongHua based on network pharmacology." Tropical Journal of Pharmaceutical Research 19.7 (2020): 1441-1448.https://doi.org/10.4314/tjpr.v19i7.16 39. Yu, Lu, et al. "Hydroxysafflor yellow a confers neuroprotection from focal cerebral ischemia by modulating the crosstalk between JAK2/STAT3 and SOCS3 signaling pathways."?Cellular and molecular neurobiology?(2020): 1-11. 38. Zhou, Donglai, et al. "Hydroxysafflor Yellow A mitigated myocardial ischemia/reperfusion injury by inhibiting the activation of the JAK2/STAT1 pathway." International journal of molecular medicine 44.2 (2019): 405-416.https://doi.org/10.3892/ijmm.2019.4230 37. Wu, Na, et al. "Hydroxysafflor yellow A promotes apoptosis via blocking autophagic flux in liver cancer."?Biomedicine & Pharmacotherapy?136 (2021): 111227.https://doi.org/10.1016/j.biopha.2021.111227 36. 黃楷迪,劉敬霞,牛陽,馬學琴,張婷,卜凡淑,任慧,郭盛,錢大瑋,段金廒.回藥扎里奴思方UPLC指紋圖譜結合多成分含量測定的質控方法研究[J].南京中醫(yī)藥大學學報,2021,37(01):77-82. 35. 李燕霞,王琳,姚弘毅.HSYA對骨關節(jié)炎大鼠膝關節(jié)軟骨損傷的修復作用研究[J].局解手術學雜志,2021,30(03):195-199. 34. 謝飛,周美蘭.羥基紅花黃色素A抑制高糖誘導的小鼠腎足細胞損傷[J].基礎醫(yī)學與臨床,2021,41(01):27-32. 33. 支旭然 劉洪濤 吳茵 等. UPLC-MS/MS法同時測定腎康注射液中7個有效成分[J]. 藥物分析雜志 2017 037(001):37-42. 32. 李正, 潘萬芳, 朱立明,等. 基于物質流分析的丹紅注射液制藥過程質量控制研究[J]. 天津中醫(yī)藥大學學報, 2015, 34(06):349-352. 31. 支旭然 董占軍 吳茵 等. HPLC同時測定腎康注射液中的4種成分[J]. 華西藥學雜志 2017(03):297-299. 30. 黃趙剛, 程鋼, 湯浩,等. 血必凈注射液指紋圖譜研究[J]. 中國醫(yī)院藥學雜志, 2018, 038(022):2323-2327. 29. 艾進超 何昱 楊榮兵 等. 丹紅注射液中主要有效成分在腦缺血大鼠體內藥動學研究[J]. 中草藥 2015 46(20):79-84. 28. 劉雪 石曉倩 吳晏杰 等. UPLC法同時測定新安名方腦絡欣通中5個活性成分的含量[J]. 貴陽中醫(yī)學院學報 2020年42卷4期 26-31頁 ISTIC 2020. 27. 馬夢雪 吳士筠 李剛 等. HPLC法同時測定不同品種紅花中4種黃酮類[J]. 中成藥 2019 041(011):2694-2700. 26. 方雨晨, 萬海同, 虞立,等. 谷紅注射液主要有效成分在腦缺血模型大鼠體內的藥動學研究[J]. 中國中藥雜志, 2018, 043(009):1940-1945. 25. 王亞洲, 楊春旭. 蝎龍酒質量標準研究[J]. 中國實驗方劑學雜志, 2012, 18(23):105-108. 24. 王亞洲. 蝎龍接骨散質量標準研究[J]. 黑龍江醫(yī)藥, 2012, 25(6):845-847. 23. 易麗娟, 李雅, 鄒蘇蘭,等. 基于正交試驗設計與BP神經網絡優(yōu)化益氣活血方水提工藝研究[J]. 中草藥, 2019, v.50;No.653(18):50-57. 22. 王亞洲. HPLC法同時測定蝎龍酒中芍藥苷 羥基紅花黃色素A和阿魏酸[J]. 中成藥 2012 34(010):1925-1928. 21. 王亞洲 楊春旭. HPLC同時測定蝎龍接骨散中羥基紅花黃色素A和阿魏酸的含量[J]. 中國實驗方劑學雜志 2012 18(22):109-111. 20. 陳俊奎, 萬海同, 周惠芬,等. 谷紅注射液在腦缺血再灌注大鼠體內藥動學與抗氧化作用關聯(lián)性研究[J]. 中草藥, 2016, 47(003):447-453. 19. 施笑暉, 唐映紅, 陳建真,等. 谷紅注射液中羥基紅花黃色素A在大鼠體內的藥動學研究[J]. 中成藥, 2015, 037(011):2387-2391. 18. 潘璐佳, 萬海同, 陳俊奎,等. 谷紅注射液中2種成分對腦缺血大鼠氨基酸類神經遞質釋放的協(xié)同作用[J]. 中成藥, 2019, 041(004):784-788. 17. 吳鴻,雷震,高水波,張玲霞,代麗萍.羥基紅花黃色素A通過抑制微小RNA-1表達對H9c2心肌細胞氧化損傷的保護作用[J].北京中醫(yī)藥大學學報,2018,41(08):636-641. 16. 萬甜,吳敏瑞,齊振熙.羥基紅花黃色素A對激素誘導骨髓間充質干細胞成骨分化的影響[J].中國骨傷,2014,27(03):224-228. 15. 齊振熙, 吳敏瑞, 萬甜,等. 羥基紅花黃色素A對激素誘導骨髓間充質干細胞ERK1/2的干預作用[J]. 康復學報, 2014, 24(002):13-16. 14. 侯兆陽, 陳哲, 魏家森. 羥基紅花黃色素A對急性脊髓損傷模型大鼠神經細胞凋亡的影響[J]. 浙江中西醫(yī)結合雜志, 2014, 000(009):753-756. 13. 齊振熙,萬甜,吳敏瑞,張占勇,仲衛(wèi)紅,于濤.羥基紅花黃色素A不同給藥方式對激素性股骨頭缺血壞死模兔ERK1/2、JNK和p38蛋白表達的影響[J].中華中醫(yī)藥雜志,2014,29(09):2927-2930. 12. 樊啟猛, 劉潤南, 賀鵬,等. 經典名方單味藥材群體指紋圖譜信息熵及一次投料量研究[J]. 時珍國醫(yī)國藥, 2020年31卷4期, 975-979頁, PKU CSCD CA, 2020. 11. 萬甜,吳敏瑞,齊振熙.紅花提取物對激素性股骨頭缺血壞死兔股骨頭組織ERK、JNK和P38蛋白表達的影響[J].中醫(yī)雜志,2013,54(23):2039-2042. 10. 杜紅芳, 耿魁魁, 李冬梅,等. 注射用紅花黃色素與6種輸液配伍的穩(wěn)定性[J]. 中成藥, 2014, 036(008):1635-1640. 9. 特日格樂, 韓曉靜, 寶樂爾,等. 正交試驗優(yōu)選蒙藥紅花最佳醇提工藝[J]. 智慧健康, 2020, 006(007):47-48. 8. 李海英, 賀鵬, 樊啟猛,等. 桃紅四物湯HPLC指紋圖譜的總量統(tǒng)計矩及一次穩(wěn)態(tài)投料量分析. 中國實驗方劑學雜志. 7. ]賀智勇,鄒弢,羅田,李婉蓉,楊佳佳,劉學,肖婷,周雪,吳林菁,劉文,沈祥春,陶玲.基于薄荷油為油相的紅花提取物自微乳凝膠遞送系統(tǒng)制備研究[J].中草藥,2020,51(11):2922-2928. 6. 杜輝 馬永強 李春陽 等. 響應面法優(yōu)化復合酶提取紅花黃色素工藝[J]. 南方農業(yè)學報 2015 46(004):657-663. 5. 范紅晶 虞立 金偉鋒 李敏 周靜 李曉紅 張宇燕.原兒茶醛與羥基紅花黃色素A單用與合用在高脂血癥大鼠體內的藥動學-藥效學相關性研究[J].中國中藥雜志 2017 42(13):2564-2570. 4. 朱振洪 黃小飛 王玉 周郡 潘利峰 萬海同.丹紅注射液與羥基紅花黃色素A對大鼠腦缺血再灌注后IL-1β、TNF-α和Caspase-3 mRNA表達的影響[J].中華中醫(yī)藥雜志 2016 31(04):1390-1393. 3. 李宵 吳茵 支旭然 等. UPLC-MS/MS同時測定谷紅注射液中7種有效成分[J]. 中國實驗方劑學雜志 2017(21):64-69. 2. 徐森玲 萬海同 金湛 等. PHPLC法同時分離純化紅花中2種成分[J]. 中成藥 2017 39(002):436-439. 1. 陳娟 周曄 陳偉華 等. ICU超劑量谷紅注射液成品輸液的合理性考察[J]. 臨床合理用藥雜志 2018 11(31):18-21.